LANTHANUM CARBONATE
| Brand name | FOSRENOL |
|---|---|
| Active ingredient | LANTHANUM CARBONATE |
| Strength | EQ 1GM BASE |
| Dosage form | POWDER |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | September 2014 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8980327 | December 2030 | product |
| 9023397 | December 2030 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.